LANE ALDERSON: Open Payments
NPI 1851024996 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 20 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $76 · 2025 $651
Food & beverage: $551Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $265 |
| Amgen Inc. | 1 | $124 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $68 |
| Astellas Pharma Global Development | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| ABBVIE INC. | 1 | $27 |
| Organon LLC | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| MILLICENT US INC | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Veozah, EVENITY, MYFEMBREE, QULIPTA, NEXPLANON, Mirena, INTRAROSA, Cologuard Collection Kit.
Industry payments across AR — which companies pay providers there.
